Emma Langley, Ph.D.

Emma Langley, Ph.D. has a wealth of experience in research and development, medical writing, and biotechnology. From 2018 to present, they have served as the Vice President of Research & Development at Trutino Biosciences, a research-driven biopharmaceutical company. In 2017, they were a consultant providing medical writing support and experimental data review and interpretation assistance. From 2016 to 2011, they worked at Pierian Biosciences as the Associate Director of Research and Development PathwayIntel, Prometheus Laboratories Inc., A Nestl\u00e9 Health Science Company as Senior Research Scientist I and Research Scientist II, and Biogen Idec Inc. as Research Scientist I, Oncology Discovery group. From 2004 to 1998, they were a Special Research Fellow of the Leukemia & Lymphoma Society and Postdoctoral Researcher at The Scripps Research Institute. Emma began their career in 1993 as a Teaching Assistant at Universit\u00e9 Louis Pasteur.

Emma Langley, Ph.D. received their Doctor of Philosophy in Molecular and Cell Biology from Universit\u00e9 Louis Pasteur (Strasbourg I). Prior to that, they earned a Master of Science in Biochemistry from the same university, and a Bachelor of Science in Biochemistry from Universit\u00e9 Louis Pasteur (Strasbourg, France).